Edition:
United States

People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,638.50GBp
26 Jul 2016
Change (% chg)

-15.00p (-0.32%)
Prev Close
4,653.50p
Open
4,675.00p
Day's High
4,696.00p
Day's Low
4,628.50p
Volume
1,905,882
Avg. Vol
2,669,345
52-wk High
4,701.51p
52-wk Low
3,680.00p

Berger, Genevieve 

Professor Genevieve Berger is Non-Executive Director of AstraZeneca Plc., effective April 26, 2012. She was Chief Science Officer at Unilever PLC and a member of the Unilever Leadership Executive from 2008 to April 2014. She holds three doctorates – in physics, human biology and medicine – and was appointed Professor of Medicine at Université Pierre et Marie Curie, Paris in 2006. Her previous positions include Professor and Hospital Practitioner at l’Hôpital de la Pitié-Salpêtrière, Paris; Director of the Biotech and Agri-Food Department, then Head of the Technology Directorate at the French Ministry of Research and Technology; Director General, Centre National de la Recherche Scientifique; and Chairman of the Health Advisory Board of the EU Commission.

Basic Compensation

Total Annual Compensation, GBP 85,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 85,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --